Why this question matters in midlife
If you’re exploring hormone therapy for perimenopause or menopause symptoms, you’ll quickly run into two categories: FDA-approved hormone therapy and compounded hormone therapy. They can sound similar, especially when both are described as “bioidentical,” but they are not the same in how they’re made, tested, and monitored.
Below is a clear comparison to help you make a confident, informed choice, ideally with a clinician who specializes in midlife hormone care.
Quick definitions
FDA-approved hormone therapy
These are hormone medications that have been reviewed and approved by the FDA for specific uses, doses, and forms. They’re produced by regulated manufacturers and dispensed by standard pharmacies.
Compounded hormone therapy
These are custom-made formulations prepared by a compounding pharmacy, often based on a prescriber’s request for a specific dose or delivery method. Compounded products are not FDA-approved.
Side-by-side comparison: what’s different?
1) Safety and quality testing
FDA-approved: Must meet strict requirements for purity, potency, stability, and consistent absorption. Side effects and risks are studied in clinical trials.
Compounded: The individual ingredients may be FDA-approved, but the final compounded product is not evaluated by the FDA in the same way. Quality can vary between pharmacies and batches.
2) Dose consistency
FDA-approved: You can expect reliable dosing from one refill to the next.
Compounded: Dose uniformity may be less predictable, which matters when you’re trying to relieve symptoms while keeping your uterine lining and overall risk profile in mind.
3) Evidence and prescribing guidance
FDA-approved: Supported by clear prescribing guidelines, safety labeling, and research on outcomes, including symptom relief and risk considerations.
Compounded: Often marketed as “custom” or “more natural,” but there is typically less high-quality evidence on long-term safety and effectiveness for specific compounded combinations.
4) Insurance coverage and cost
FDA-approved: Often covered by insurance plans and may have generic options.
Compounded: Frequently cash-pay and may cost more over time, depending on the formulation.
5) When compounding may be appropriate
Compounded hormones can be helpful in limited situations, for example:
- When a patient has an allergy or sensitivity to a specific ingredient in an FDA-approved product.
- When a needed dose or form truly isn’t available commercially.
The key is making sure there’s a clear medical reason, and that you’re working with a clinician who understands both benefits and limitations.
Common confusion: “bioidentical” does not automatically mean compounded
It is important to note that “bioidentical” is often used as a marketing term and can imply “safer” or “more natural,” although that is not necessarily accurate. Many FDA-approved hormone therapies are bioidentical, meaning their molecular structure is identical to hormones produced by the body (such as estradiol and micronized progesterone). Compounded hormones are not the only route to bioidentical therapy.
If you’re new to all of this, start with our menopause and perimenopause resources to understand what symptoms can improve with the right approach: Menopause and Perimenopause.
How to choose: a practical recommendation
For most people, FDA-approved hormone therapy is the preferred first-line option because dosing and safety are better established.
Compounded hormone therapy may be worth discussing if you have a specific need that FDA-approved options cannot meet, but it should be approached thoughtfully, with a clear rationale and close follow-up.
At Midlife Wellness, we focus on evidence-based, personalized care and talk through the pros and cons in plain language. You can explore options on our Treatments page, or if you’re ready to discuss what fits your symptoms and health history, reach out through Contact Us.
Important: This article is for education and does not replace medical advice. Hormone therapy should be individualized, especially if you have a uterus, a history of blood clots, certain cancers, or complex risk factors.